ZM-02

· Zhongmou Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZM-02, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients [EARLY_Phase 1]